Masaki Hiraguri

779 total citations
15 papers, 404 citations indexed

About

Masaki Hiraguri is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Masaki Hiraguri has authored 15 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Masaki Hiraguri's work include Vasculitis and related conditions (6 papers), Eosinophilic Disorders and Syndromes (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Masaki Hiraguri is often cited by papers focused on Vasculitis and related conditions (6 papers), Eosinophilic Disorders and Syndromes (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Masaki Hiraguri collaborates with scholars based in Japan. Masaki Hiraguri's co-authors include Itsuo Iwamoto, Kazuhiro Kurasawa, Yasushi Saito, Satoshi Miike, Atsuhito Nakao, Makoto Kawai, Kei Ikeda, Yoshihiro Kita, Shunsuke Furuta and Y Nawata and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Leukocyte Biology and Lara D. Veeken.

In The Last Decade

Masaki Hiraguri

14 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaki Hiraguri Japan 9 248 160 132 104 58 15 404
Koji Kitagori Japan 11 233 0.9× 98 0.6× 96 0.7× 135 1.3× 20 0.3× 47 424
Gudrun Reynisdottir Sweden 6 347 1.4× 237 1.5× 67 0.5× 114 1.1× 98 1.7× 12 563
Eun Bong Lee South Korea 11 215 0.9× 77 0.5× 214 1.6× 151 1.5× 16 0.3× 14 509
Boaz Palterer Italy 12 157 0.6× 49 0.3× 133 1.0× 111 1.1× 49 0.8× 33 362
Hiroyuki Hagiyama Japan 12 102 0.4× 48 0.3× 145 1.1× 85 0.8× 29 0.5× 20 375
L. Burke United States 8 111 0.4× 117 0.7× 80 0.6× 62 0.6× 39 0.7× 11 374
Gonçalo Boleto France 10 89 0.4× 83 0.5× 47 0.4× 87 0.8× 32 0.6× 23 278
Obbo W Bredewold Netherlands 10 224 0.9× 114 0.7× 25 0.2× 185 1.8× 26 0.4× 24 429
Alicia Rodríguez-Pla United States 10 159 0.6× 261 1.6× 30 0.2× 122 1.2× 21 0.4× 27 387
Rafah Salloum United States 7 237 1.0× 90 0.6× 40 0.3× 271 2.6× 109 1.9× 8 472

Countries citing papers authored by Masaki Hiraguri

Since Specialization
Citations

This map shows the geographic impact of Masaki Hiraguri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Hiraguri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Hiraguri more than expected).

Fields of papers citing papers by Masaki Hiraguri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Hiraguri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Hiraguri. The network helps show where Masaki Hiraguri may publish in the future.

Co-authorship network of co-authors of Masaki Hiraguri

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Hiraguri. A scholar is included among the top collaborators of Masaki Hiraguri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Hiraguri. Masaki Hiraguri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Furuta, Shunsuke, Michio Fujiwara, Masaki Hiraguri, et al.. (2024). Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Lara D. Veeken. 64(2). 756–762. 3 indexed citations
2.
3.
Furuta, Shunsuke, Daiki Nakagomi, Y Kobayashi, et al.. (2023). Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study. Annals of the Rheumatic Diseases. 83(1). 96–102. 12 indexed citations
4.
Sugiyama, Takahiro, Shunsuke Furuta, Masaki Hiraguri, et al.. (2022). Latent class analysis of 216 patients with adult-onset Still’s disease. Arthritis Research & Therapy. 24(1). 7–7. 16 indexed citations
5.
Nakagomi, Daiki, Shunsuke Furuta, M. Yamagata, et al.. (2020). Efficacy of rituximab for anti-neutrophil cytoplasmic antibody-associated hypertrophic pachymeningitis: a case series.. PubMed. 38 Suppl 124(2). 176–181. 2 indexed citations
6.
7.
Ikeda, Kei, Kotaro Iida, Kazuo Suzuki, et al.. (2018). Disseminated toxoplasmosis with atypical symptoms which developed with exacerbation of systemic lupus erythematosus. Lupus. 28(1). 133–136. 5 indexed citations
8.
Furuta, Shunsuke, Masaki Hiraguri, Kei Ikeda, et al.. (2018). Longterm Outcomes of 188 Japanese Patients with Eosinophilic Granulomatosis with Polyangiitis. The Journal of Rheumatology. 45(8). 1159–1166. 44 indexed citations
9.
10.
11.
12.
13.
Nawata, Y, Kazuhiro Kurasawa, Katsuhiko Takabayashi, et al.. (1999). Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.. PubMed. 26(7). 1527–33. 115 indexed citations
14.
Nakao, Atsuhito, Masaki Hiraguri, Satoshi Miike, et al.. (1999). Tumor Necrosis Factor-α Mediates Antiapoptotic Signals Partially via p38 MAP Kinase Activation in Human Eosinophils. International Archives of Allergy and Immunology. 120(Suppl. 1). 54–59. 27 indexed citations
15.
Miike, Satoshi, Atsuhito Nakao, Masaki Hiraguri, et al.. (1999). Involvement of JAK2, but not PI 3-kinase/Akt and MAP kinase pathways, in anti-apoptotic signals of GM-CSF in human eosinophils. Journal of Leukocyte Biology. 65(5). 700–706. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Kitagori Breakdown of academic impact, for papers by Gudrun Reynisdottir Breakdown of academic impact, for papers by Eun Bong Lee Breakdown of academic impact, for papers by Boaz Palterer Breakdown of academic impact, for papers by Hiroyuki Hagiyama Breakdown of academic impact, for papers by L. Burke Breakdown of academic impact, for papers by Gonçalo Boleto Breakdown of academic impact, for papers by Obbo W Bredewold Breakdown of academic impact, for papers by Alicia Rodríguez-Pla Breakdown of academic impact, for papers by Rafah Salloum
Rankless by CCL
2026